Xiamen Amoytop Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 419.31 million compared to CNY 345.01 million a year ago. Revenue was CNY 419.31 million compared to CNY 345.01 million a year ago.

Net income was CNY 84.17 million compared to CNY 57.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.14 a year ago.